Author

Raghava Reddy Kethiri

Observed names: Ragahava Reddy Kethiri, Raghava R Kethiri

Observed institution: Jubilant Life Sciences (India)

OpenAlex ID: A5021908899

Rational design, synthesis, biological evaluation and molecular docking studies of chromone-pyrimidine derivatives as potent anti-cancer agents

2021 · Abhijit Kantankar, Y. Jayaprakash Rao, et al. · Journal of Molecular Structure · 35

Leucine-rich repeat kinase 2 inhibitors: a review of recent patents (2011 – 2013)

2014 · Raghava R Kethiri, Rajagopal Bakthavatchalam · Expert Opinion on Therapeutic Patents · 31

Validated RP‐HPLC/UV method for the quantitation of abiraterone in rat plasma and its application to a pharmacokinetic study in rats

2012 · S. Vijay Kumar, G. Rudresha, et al. · Biomedical Chromatography · 29

Determination of ulixertinib in mice plasma by LC–MS/MS and its application to a pharmacokinetic study in mice

2016 · Rajinish Kumar, P.S. Suresh, et al. · Journal of Pharmaceutical and Biomedical Analysis · 13

Preclinical assessment of Orteronel®, a CYP17A1 enzyme inhibitor in rats

2014 · Mohd Zainuddin, A. B. Vinod, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 5

Discovery of Selective Dual Inhibitors of Bromodomain Protein BRD4 and JAK2 for Treatment of Hematologic Malignancies

2016 · Ram S. Upadhayaya, Raghava Reddy Kethiri, et al. · Blood · 3

Development And Validation of A Highly Sensitive Lc–Esi-MS/MS Method For The Determination of Orteronel ® (Tak-700) in Rat Plasma: Application to A Pharmacokinetic Study

2012 · Sandip Gurav, Anitha Police, et al. · Bioanalysis · 2

Abstract C134: EN3356, a novel CYP17A inhibitor for the treatment of castration resistant prostate cancer.

2013 · Nicholas J. Laping, Dhanalakshmi Sivanandhan, et al. · Molecular Cancer Therapeutics · 1

Development and validation of an RP‐HPLC method for the quantitation of Orteronel (TAK‐700), a CYP17A1 enzyme inhibitor, in rat plasma and its application to a pharmacokinetic study

2013 · Avinash Kumar, Vijay Kumar S, et al. · Biomedical Chromatography · 1

Abstract 3067: OHM-581, a dual JAK2-BET inhibitor for the treatment of myelofibrosis and other hematologic malignancies

2019 · Ram S. Upadhayaya, Raghava Reddy Kethiri, et al. · Cancer Research

Abstract 187: ASN0007, a potent ERK1/2 inhibitor with strong antitumor activity in multiple RAS mutant models

2016 · Sanjeeva P. Reddy, Dhanalakshmi Sivanandhan, et al. · Cancer Research

Development and validation of an enantioselective LC‐MS/MS method to quantify enantiomers of (±)‐TAK‐700 in rat plasma: lack of in vivo inversion of (+)‐TAK‐700 (Orteronel) to its antipode

2012 · Sandip Gurav, Anitha Police, et al. · Biomedical Chromatography

Works count: 12

Citation count: 120

H-index: 5

I10-index: 4